Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity

Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4

(2013) M. E. Jaax et al.   BLOOD

Dynamic antibody-binding properties in the pathogenesis of HIT

(2012) B. S. Sachais et al.   BLOOD

Binding of heparin-dependent antibodies to PF4 modified by enoxaparin oligosaccharides: evaluation by surface plasmon resonance and serotonin release assay

(2012) D. LEROUX et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Disruption of PF4/H multimolecular complex formation with a minimally anticoagulant heparin (ODSH)

(2012) Manali V. Joglekar et al.   THROMBOSIS AND HAEMOSTASIS

Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series

(2011) T. E. WARKENTIN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Platelet factor 4 binds to bacteria, inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia

(2010) K. Krauel et al.   BLOOD

Aggregated Recombinant Human Interferon Beta Induces Antibodies but No Memory in Immune-Tolerant Transgenic Mice

(2010) Miranda M. C. van Beers et al.   PHARMACEUTICAL RESEARCH

Heparin-induced thrombocytopenia - therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes

(2008) K. KRAUEL et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS